Tessier-Lavigne Marc

CIK 00014374356 companiesSO SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001437435

Recent Transactions

50 trades

Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2025-06-03+18,111→ 18,111 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2025-06-03+6,037→ 1,886,576 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2024-05-31+17,901→ 17,901 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2024-05-31+5,967→ 1,880,539 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2023-06-01+4,216→ 1,874,572 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-06-01+12,649→ 12,649 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-01-03+1,929→ 1,929 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-01-03+165→ 2,434 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-01-03+165→ 2,434 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-01-03+1,929→ 1,929 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-11-23$30.48/sh−20,000→ 1,870,356 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-11-02$30.33/sh−11,252→ 1,890,356 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-11-01$30.20/sh−8,748→ 1,901,608 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-10-03$718.00/sh−3,612→ 2,269 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2022-10-03−3,612→ 0 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-10-03$413.33/sh+3,612→ 5,881 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2022-09-30−3,428→ 3,612 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-30$413.33/sh+3,428→ 5,697 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-30$698.00/sh−3,428→ 2,269 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-29$699.82/sh−80→ 2,305 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-29$687.90/sh−321→ 5,730 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-29$691.59/sh−554→ 2,838 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-29$690.65/sh−692→ 3,392 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-29$686.89/sh−16→ 6,051 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-29$704.83/sh−20→ 2,269 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-29$688.71/sh−637→ 5,093 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2022-09-29−3,798→ 7,040 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-29$697.29/sh−160→ 2,593 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-29$689.56/sh−1,009→ 4,084 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-29$702.36/sh−16→ 2,289 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-29$696.13/sh−85→ 2,753 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-29$413.33/sh+3,798→ 6,067 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-09-29$698.44/sh−208→ 2,385 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-09-28$31.08/sh−4,423→ 1,910,356 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-09-28$30.74/sh−15,577→ 1,914,779 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-08-23$32.43/sh−100→ 1,930,356 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-08-23$31.61/sh−19,900→ 1,930,456 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-07-25$35.60/sh−19,800→ 1,950,556 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-07-25$36.15/sh−200→ 1,950,356 total
Disposition to Issuer
Denali Therapeutics Inc.$DNLI
Common Stock
2022-06-24$31.08/sh−6,766→ 1,970,356 total
Disposition to Issuer
Denali Therapeutics Inc.$DNLI
Common Stock
2022-06-24$30.53/sh−39,984→ 1,977,122 total
Disposition to Issuer
Denali Therapeutics Inc.$DNLI
Common Stock
2022-06-23$31.10/sh−13,250→ 2,017,106 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2022-06-02+17,959→ 17,959 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2022-06-02+5,986→ 2,030,356 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-03-23$34.14/sh−11,598→ 2,024,370 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-03-23$33.40/sh−8,402→ 2,035,968 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-03-23$34.14/sh−11,598→ 2,024,370 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-03-23$33.40/sh−8,402→ 2,035,968 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2022-03-21−7,439→ 0 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-03-21$380.95/sh+7,439→ 9,708 total

Companies

Recent Filings

Address

1 DNA WAY

SO SAN FRANCISCO, CA, 94080

View on SEC.gov